The Department of Defense (DOD) awarded a $410,596 Project Grant under the Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630) to Claflin University, an Historically Black College and University (HBCU) located in Orangeburg, South Carolina. The grant, awarded on September 1, 2024, will support a range of scientific research and technological development initiatives at the university over a one-year period, with a final completion date of August 31, 2025....
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The Defense Health Agency awarded Duke University a $1,167,250 Project Grant (CFDA 12.420 - Military Medical Research and Development) with a performance period from June 1, 2024 to May 31, 2027. The grant funding supports Duke's research on the role of the NLRP3-NLRC5 signaling pathway in melanoma immune evasion and dormancy. The research aims to advance the understanding of mechanisms underlying melanoma progression, with the potential to inform new therapeutic approaches. As a prominent...
The University of Cambridge received a $824,548 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on understanding the role of hypoxia in vasculogenic mimicry, response to therapy, and metastasis. This 3-year grant awarded on May 1, 2024 will support basic, translational, and clinical research to advance scientific understanding and develop new treatments in areas such as cancer, neurological...
The Department of Defense's Defense Health Agency awarded a $558,832 Project Grant to Tufts University School of Medicine under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2024. This grant will support research focused on "Targeting Differentiation Epitope in CD11b of Tumor-Associated Inflammatory Monocytes: A Novel Adjuvant Dendritic Cell Therapy Approach for Mucosal Melanoma." The research aims to develop an innovative dendritic cell-based...
The University of Virginia received a $921,351 project grant award on September 30, 2023 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to support research on "APPROACHES TO ENHANCE VACCINE-INDUCED TUMOR-INFILTRATING LYMPHOCYTES (VITILS) IN MELANOMA". This multi-year grant, scheduled for completion on September 29, 2026, aims to advance biomedical research that can transform healthcare for Service Members and the American public. The...
This Project Grant award, with a total funding amount of $507,813.00, was provided by the U.S. Department of Defense under the Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630). The award, titled "BEYOND THE CLOCK: UNDERSTANDING CROSS-CULTURAL TEMPORAL ORIENTATION OF MILITARY OFFICERS," is focused on research to advance understanding of cross-cultural temporal orientation among military officers. The primary awardee is Old Dominion University, which...
The U.S. Department of Defense (DoD) awarded a $784,963 Project Grant to the University of California, Irvine (UC Irvine) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, which began on September 15, 2023, funds research focused on "Interactions of Fine Particulate Matter Exposure and Gonadal Toxicity on Alzheimer's Disease Progression." UC Irvine, as a leading public research university with expertise across biomedical disciplines, will...
This $819,195 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Drexel University on the PEDF PLXDC1 ADNP signaling pathways related to neuromorphogenesis and neural circuit development. The award, which runs from September 15, 2023 to September 14, 2026, will fund basic, translational, and clinical research aimed at advancing scientific understanding and developing new treatments in areas such as...